Rosacea. Rosacea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Suffering from rosacea Not receiving other treatments in the last three months Eligible men and women from 18 to 60 years with severe erythema rosacea based on a patient self-assessment (PSA) score of 4 (severe) and a physician evaluation of erythema (CEA) score of 3 or more have the ability to enter the study
Exclusion criteria
Exclusion criteria: causing severe drug side effects Those who had more than 5 inflammatory lesions on the face (pointy acne or purulent acne) Specific forms of rosacea (rosacea conglobata, rosacea fulminans, isolated rhinophyma, isolated pastilosis of the chin) They had other facial dermatitis similar to rosacea (such as perioral dermatitis), dimadisidosis, keratinization, seborrheic dermatitis, acute lupus erythematosus, or actinic telangiectasian.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of rosacea lesions based on physician assessment (CEA). Timepoint: Before treatment and 4 and 8 weeks after. Method of measurement: Physical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of rosacea lesions based on patient self-assessment (PSA). Timepoint: Before treatment and 4 and 8 weeks after. Method of measurement: Questionnaire PSA (patient's self-assessment) (evaluating the severity of erythema and redness from the patient's perspective). | — |
Countries
Iran (Islamic Republic of)
Contacts
Skin and Stem cell Research Center of Tehran University of Medical Sciences